Shinzaki S - Search Results

1

Long-term retention of adalimumab treatment and associated prognostic factors for 1189 patients with Crohn's disease.

Tanaka H, Kamata N, Yamada A, Endo K, Fujii T, Yoshino T, Sugaya T, Yokoyama Y, Bamba S, Umeno J, Yanai Y, Ishii M, Kawaguchi T, Shinzaki S, Toya Y, Kobayashi T, Nojima M, Hibi T; ADJUST study group. Tanaka H, et al. Among authors: shinzaki s. J Gastroenterol Hepatol. 2018 May;33(5):1031-1038. doi: 10.1111/jgh.14034. Epub 2018 Mar 15. J Gastroenterol Hepatol. 2018. PMID: 29087616

2

Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's disease.

Shinzaki S, Kuroki E, Iijima H, Tatsunaka N, Ishii M, Fujii H, Kamada Y, Kobayashi T, Shibukawa N, Inoue T, Tsujii M, Takeishi S, Mizushima T, Ogata A, Naka T, Plevy SE, Takehara T, Miyoshi E. Shinzaki S, et al. Inflamm Bowel Dis. 2013 Feb;19(2):321-31. doi: 10.1097/MIB.0b013e318280eade. Inflamm Bowel Dis. 2013. PMID: 23287897

3

Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease.

Mukai A, Iijima H, Hiyama S, Fujii H, Shinzaki S, Inoue T, Shiraishi E, Kawai S, Araki M, Hayashi Y, Kondo J, Mizushima T, Kanto T, Egawa S, Nishida T, Tsujii M, Takehara T. Mukai A, et al. Among authors: shinzaki s. J Gastroenterol. 2014 Dec;49(12):1524-35. doi: 10.1007/s00535-013-0923-x. Epub 2013 Dec 20. J Gastroenterol. 2014. PMID: 24356810

4

[Effectiveness of anti-tumor necrosis factor-α therapy in Crohn's disease with abscesses around the sigmoid colon: a case report].

Nagai K, Shinzaki S, Kato M, Hiyama S, Yakushijin T, Nishida T, Iijima H, Ookawa K, Tsujii M, Takehara T. Nagai K, et al. Among authors: shinzaki s. Nihon Shokakibyo Gakkai Zasshi. 2015 Apr;112(4):707-13. doi: 10.11405/nisshoshi.112.707. Nihon Shokakibyo Gakkai Zasshi. 2015. PMID: 25843459 Japanese.

5

Safety of Emulsifying Lipid Formulation Containing Omega-3 Polyunsaturated Fatty Acids for Patients with Crohn's Disease.

Yasueda A, Shinzaki S, Iijima H, Mizushima T, Nishimura J, Hiyama S, Ohno S, Ito T. Yasueda A, et al. Among authors: shinzaki s. Anticancer Res. 2016 Jul;36(7):3753-9. Anticancer Res. 2016. PMID: 27354650 Clinical Trial.

6

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis.

Shinzaki S, Matsuoka K, Iijima H, Mizuno S, Serada S, Fujimoto M, Arai N, Koyama N, Morii E, Watanabe M, Hibi T, Kanai T, Takehara T, Naka T. Shinzaki S, et al. J Crohns Colitis. 2017 Jan;11(1):84-91. doi: 10.1093/ecco-jcc/jjw132. Epub 2016 Jul 27. J Crohns Colitis. 2017. PMID: 27466171 Free PMC article.

7

Age at onset is associated with the seasonal pattern of onset and exacerbation in inflammatory bowel disease.

Araki M, Shinzaki S, Yamada T, Arimitsu S, Komori M, Shibukawa N, Mukai A, Nakajima S, Kinoshita K, Kitamura S, Murayama Y, Ogawa H, Yasunaga Y, Oshita M, Fukui H, Masuda E, Tsujii M, Hiyama S, Inoue T, Iijima H, Takehara T. Araki M, et al. Among authors: shinzaki s. J Gastroenterol. 2017 Nov;52(11):1149-1157. doi: 10.1007/s00535-017-1313-6. Epub 2017 Feb 6. J Gastroenterol. 2017. PMID: 28168321

8

Chronic Enteropathy Associated With SLCO2A1 Gene [CEAS]-Characterisation of an Enteric Disorder to be Considered in the Differential Diagnosis of Crohn's Disease.

Hosoe N, Ohmiya N, Hirai F, Umeno J, Esaki M, Yamagami H, Onodera K, Bamba S, Imaeda H, Yanai S, Hisamatsu T, Ogata H, Matsumoto T; CEAS Atlas Group. Hosoe N, et al. J Crohns Colitis. 2017 Oct 1;11(10):1277-1281. doi: 10.1093/ecco-jcc/jjx068. J Crohns Colitis. 2017. PMID: 28510689

9

Tissue Drug Concentrations of Anti-tumor Necrosis Factor Agents Are Associated with the Long-term Outcome of Patients with Crohn's Disease.

Yoshihara T, Shinzaki S, Kawai S, Fujii H, Iwatani S, Yamaguchi T, Araki M, Hiyama S, Inoue T, Hayashi Y, Watabe K, Iijima H, Takehara T. Yoshihara T, et al. Among authors: shinzaki s. Inflamm Bowel Dis. 2017 Dec;23(12):2172-2179. doi: 10.1097/MIB.0000000000001260. Inflamm Bowel Dis. 2017. PMID: 28945638

10

Real-world Experience of Anti-tumor Necrosis Factor Therapy for Internal Fistulas in Crohn's Disease: A Retrospective Multicenter Cohort Study.

Kobayashi T, Hishida A, Tanaka H, Nuki Y, Bamba S, Yamada A, Fujii T, Shinzaki S, Yokoyama Y, Yoshida A, Ozeki K, Ashizuka S, Kamata N, Nanjo S, Kakimoto K, Nakamura M, Matsui A, Yamauchi R, Takahashi S, Tomizawa T, Yoshino T, Hibi T. Kobayashi T, et al. Among authors: shinzaki s. Inflamm Bowel Dis. 2017 Dec;23(12):2245-2251. doi: 10.1097/MIB.0000000000001276. Inflamm Bowel Dis. 2017. PMID: 29084079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

170 results

Search Page